Prosma ® is a non-bronchodilator anti-asthmatic drug with marked anti-anaphylactic property. ln addition, Prosma ® exerts a powerful and sustained H 1 receptor blocking activity which can be clearly dissociated from its anti-anaphylactic property.
No Data
Prosma ® is indicated for the treatment of alleigic conjunctivitis.
Adults and children over 3 years of age : The recommended dose is one drop in affected eye(s) 8 to12 hourly or as recommended by the physician.
Children below 3 years of age:Not recommended.
Directions for use
The following steps should be considered to assure the right use of Prosma ® .
Do not use longer than one month after opening. lt is advisable to destroy any remaining medicament after completing treatment.
No Data
Drowsiness and in isolated cases dry mouth and slight dizziness may occur at the beginning,of the treatment, but usually disappear spontaneously after a few days.
Prosma ® is contraindicated in patients with hypersensitivity to any of its ingredient.
Use in Pregnancy and Lactation: There are no clinical trials on the use of Prosma ® in pregnant or nursing women, therefore, Prosma ® should not be used during pregnancy, except if the benefit justifies the potential risk to the fetus.
Warnings: Topical use only. Not for oral use or as injection.
Precautions: As with all ophthalmic preparations containing benzalkonium chloride, patients are advised not to instill Prosma ® (Ketotifen Fumarate ophthalmic solution) while wearing soft (hydrophilic)contact lenses. Wearers of soft contact lenses should be instructed to remove lenses prior to instillation of drops and to wait at least ten minutes after instilling Prosma ® before they inserttheir contact lenses.
No Data
No Data
No Data
Store in a cool dry place. Protect from light.